Objective-To assess the efficacy of barium meal examinations in managing patients with dyspepsia in general practice.
logical abnormalities and tije influence of the examination result on management, particularly changes in drug treatment.
Results-Fully completed pairs of questionnaires were available for 100 patients, 58 of whom were aged below 50. Most of the barium meal reports (64) were to confirm the clinical diagnosis; only 22 were to exclude serious disease. Ninety nine patients were already receiving treatment, with 39 taking an H2 receptor antagonist. Fifty eight barium meal examinations showed abnormalities (31 major abnormalities); there were no cancers and in only 18 patients was the working diagnosis changed as a result of the findings. Although the barium meal result increased management confidence (63 patients) and allayed patients' anxiety (46), changes in management attributed directly to the examination occurred in only 22 patients. Management changes were minor, usually comprising interchange of antacids and H2 receptor antagonists.
Conclusions-Young patients (aged below 50) with dyspepsia are still being overinvestigated. Although barium meal examination improves diagnostic confidence and allays patients' anxiety, fully utilising communication skills at the initial consultation might allay anxiety more economically.
Introduction
The prevalence of dyspepsia in the United Kingdom remains high. Although most (71%), senior registrars (20%), and consultants (9%). All examinations performed by registrars were reviewed by a consultant or senior registrar before a report was issued.
Results
At the end of the study 100 fully completed pairs of questionnaires were available for analysis. Of the 133 patients recruited, 10 failed to attend for their examination, one refused the examination on arrival, 21 did not fully complete their questionnaire or did not return it, and two were not available for follow up. The final study group consisted of 57 men and 43 women, 58% of whom were aged under 50 and 24 under 30.
Most (64) of the 100 referrals for a barium meal examination were made to confirm the clinical diagnosis and in 21 the stated reason was to exclude serious disease; reassurance of the patient accounted for 11 and direct patient pressure for four. All but one patient attending for an examination were taking some form of treatment; 39 were taking H2 receptor antagonists, and the remainder were taking antacids or other treatment, with 22 taking more than one drug. In a quarter of patients the symptoms had already improved at the time the examination was requested. Eight patients gave a history of previously proved peptic ulceration. Tables I and II favourably with those of endoscopy in detecting peptic ulcer disease and oesophageal and gastric malignancy and in assessing hiatus hernia, gastro-oesophageal reflux, and oesophagitis.7 Barium meal examination remains an effective and popular outpatient investigation for dyspepsia, with good patient acceptability and low morbidity. The rate of abnormality of 58% in this study suggests a high diagnostic yield, although in only 31 patients (31%) was the abnormality relevant to their symptoms, thus warranting specific treatment. The rate of clinically significant abnormality was higher than that reported for chest x rays requested by general practitioners, which disclosed a relevant abnormality in 21% %8 In most of our patients, however, their condition was diagnosed clinically before the barium meal examination and the main influence of the examination was to confirm the original diagnosis and reassure the clinician that the proposed management was appropriate.
Surprisingly, most referred patients (58) were aged under 50, and the detection rate of significant abnormalities was almost identical with that of the over 50 age group, which conflicts with previous data.4 No gastrointestinal malignancy was detected in either group, although in 22% of patients the exclusion of a serious condition, usually cancer, was the main reason stated for requesting the examination. There is considerable evidence that the investigation of dyspepsia in young patients (aged under 50) is rarely rewarding in terms of management.349 The incidence of malignancy is low in this group, and such patients usually present with additional symptoms of anorexia and weight loss.'0 There may be several reasons why requests for barium meal examination continue for young patients. Standard clinical teaching dictates that a diagnosis is required before starting treatment with expensive drugs. The fact that 15 examinations were performed simply for reassurance or as a result of direct pressure from patients reflects the difficulty with empirical management, particularly in patients with recurrent dyspepsia. The therapeutic effect of normal findings on examination may be substantial in many patients, and in almost half the group studied patients' anxiety was allayed by the examination. Such reassurance may have been a factor for failure of 16 patients to consult the general practitioner after the examination.
The change in management of 40% was considerably higher than the 11% reported in young dyspeptic patients4 and compares favourably with the other commonly used tests. A study of the influence of barium enema examination for a wide range of presenting symptoms indicated that it excluded serious conditions in 64% ofpatients and changed management in 24%." In another study the plain abdominal film changed management in 10% of acute surgical admissions.'2 In most of our patients, however, the management changes entailed fairly minor manipulations, usually interchange of H2 receptor antagonists and antacids. As all but one patient were receiving the same form of treatment at the time of the examination the main influence was that of stopping treatment; all treatments were withdrawn in 14 patients and H2 receptor antagonists were withdrawn in eight at the end of follow up.
Although the resultant management changes might seem unimportant, the examination was regarded as helpful in 76 patients. The main benefit seemed to be that of increasing the diagnostic and therapeutic confidence of the referring clinician and alleviating patient anxiety. As ANY QUESTIONS Some patients are takingfish oil and evening primrose oilfor arthritis and aspirin as a preventive against vascular disorder. Is there any danger in taking these substances together?
Both fish oil and evening primrose oil affect platelet function by interfering with the production of thromboxane A2. Maxepa (fish oils) 50 ml daily inhibits platelet function to a lesser degree than does aspirin 325 mg daily. The size of the effect of evening primrose oil is uncertain but is unlikely to be greater than the effect of fish oils. Aspirin also inhibits platelet function through its effect on thromboxane A2 synthesis, and the effect would probably be additive with those of fish oils and evening primrose oil.
So far as I am aware the effects of these combinations on platelet function have not been measured. The risk of bleeding, however, may be greater if the three substances are taken in combination; the effect of fish oils and evening primrose oil in combination may be greater than that of either alone-perhaps roughly equivalent to that of 325 mg aspirin. 
